Thyrocare Technologies Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
THYROCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Thyrocare Technologies has informed the exchanges that its trading window will be closed from July 1, 2025, in line with SEBI's insider trading regulations. The window applies to promoters, directors, designated employees, and their immediate relatives, preventing them from trading in the company's shares during this period. The window will reopen 48 hours after the company announces its unaudited financial results for the quarter ended June 30, 2025 (Q1 FY26). The date of the board meeting to approve these results will be communicated later. This is a routine compliance measure taken before quarterly results.
This is a standard regulatory disclosure and does not directly affect the stock price, but it signals that Thyrocare's Q1 FY26 earnings announcement is approaching, which investors should watch for.